In total, Novo's share price has fallen for five straight days, and is now down a combined 8.5%. It doesn't help of course, that just yesterday The Fly reported investment bank Morgan Stanley had ...

More than 54.5 crore JanDhan accounts have been opened till January 15, 2025, with about 56 per cent belonging to women, according to Finance Minister Nirmala Sitharaman. The government initiated ...

17:32 EST Conduit Pharmaceuticals (CDT) files to sell 5.9M shares of common stock for holders Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

Novo Nordisk (NVO) announced Friday that its popular ... the Danish drugmaker said that while patients on regular Wegovy at 2.4 mg achieved 17.5% weight loss over the period, those on placebo ...

Novo Nordisk closed up 4.5% Wednesday. Shares of obesity drug rival Eli Lilly, meanwhile, rose 1.4%. Speaking to CNBC Wednesday, CEO and President Lars Fruergaard Jørgensen said that the company ...

Novo Nordisk shares rose Wednesday after fourth-quarter earnings beat Wall Street's estimates, 2025 forecast came in line with expectations. Novo CEO Lars Fruergaard Jorgensen sees Wegovy supply ...

16.2% with 5 milligrams over 28 weeks, and 22.1% with 20 milligrams over 36 weeks. The most common side effects were gastrointestinal, with the vast majority mild to moderate in severity. Novo ...

Scientists at the University of Southern California monitored 48 people with alcohol use disorder, which can leave people with the inability to control their drinking despite negative consequences ...

Novo Nordisk A/S rose the most since August 2023 after its experimental shot delivered as much as 22% weight loss in an early-stage trial, boosting investors’ hopes for the drugmaker’s pipeline.

Lone Star Funds is selecting advisers to explore a possible sale or initial public offering of Portuguese lender Novo Banco SA, according to people familiar with the matter. The private equity ...

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this. On rare occasions, our expert team of analysts issues a “Double Down” stock ...